[Shortsighted economics behind the choice of HPV vaccine. Sweden misses the chance the chance "to eradicate" condyloma].
Rylander
Eva
E
Karolinska institutet, Stockholm. eva.rylander@ki.se
D000293:Adolescent; D000328:Adult; D002648:Child; D003218:Condylomata Acuminata / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D032541:Mass Vaccination / Q000191:economics; D053918:Papillomavirus Vaccines / Q000008:administration & dosage / Q000191:economics*; D013548:Sweden; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology
D053918:Papillomavirus Vaccines